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Background: The novel group treatment program Training for Awareness, Resilience, 
and Action (TARA) was developed to target specific mechanisms based on neurosci-
ence findings in adolescent depression and framed within the National Institute of Mental 
Health Research Domain Criteria. TARA contains training of autonomic and emotional 
self-regulation, interoceptive awareness, relational skills, and value-based committed 
action.
Methods: We performed a single-arm trial to test the feasibility and preliminary efficacy 
of TARA in reducing depression and anxiety levels and assessed whether the specific 
targeted domains of function reflected the hypothesized symptom change. Twenty-six 
adolescents (14–18  years old, 7 males and 19 females) participated in the 12-week 
group program. Assessment was performed before (T0), immediately after (T1), and 
3 months after the end of TARA (T2).
results: Significant improvement was seen in depression symptoms (Reynolds 
Adolescent Depression Scale Second Edition) between T0–T1 (t-value  =  −3.56, 
p = 0.002, CI = −6.64, −1.77) and T0–T2 (t-value = −4.17, p < 0.001, CI = −11.20, 
−3.75) and anxiety symptoms (Multidimensional Anxiety Scale for Children) between 
T0–T1 (t-value = −2.26, p = 0.033, CI = −4.61, −0.21) and T0–T2 (t-value = −3.06, 
p = 0.006, 95% confidence interval = −9.02, −1.73). Significant improvements in psy-
chological flexibility, sleep, and mindfulness skills were also found between T0 and T2.
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inTrODUcTiOn
More effective treatment of adolescent depression is critically 
needed given that global projections by the World Health 
Organization identify major depressive disorder (MDD) as 
the leading cause of disease burden by 2030 (1). This is partly 
explained by a combination of the age distribution of the global 
population and the sharp increase of onset of MDD during the 
teenage years, with a current lifetime prevalence of 11.0% in this 
age group (2). Early onset depression predicts a fourfold increase 
in the risk of developing adult depression and is associated with 
higher risk of future negative health outcomes and suicide (3). 
Furthermore, the relapse rate 5 years after remission is 70% (4).
One way to address this problem is to close the current gap in 
the translation between the rapidly growing body of literature on 
neural mechanisms characterizing adolescent depression and the 
development of targeted treatments. Such an attempt has been 
made through the development of a novel treatment approach 
for adolescent depression Training for Awareness, Resilience, and 
Action (TARA) (5) aligned with the Research Domain Criteria 
(RDoC) of the National Institute of Mental Health (NIMH) (6). 
The preliminary conceptual framework of TARA has been previ-
ously described (5). Our approach to use the RDoC in combina-
tion with developmental aspects of the brain as the foundation for 
creating a treatment model for adolescent depression is pioneering 
work. We appreciate the complexity of the different neurocircuits 
implied in adolescent depression and the difficulty to disentangle 
them, since overlaps between different domains and constructs 
in the RDoC matrix are common. We have therefore reduced 
our targets for the TARA treatment model to specific neural 
mechanisms rather than all of the neurocircuitry suggested in 
each construct. We were inspired by a similar development of an 
RDoC-based approach for treatment of geriatric depression that 
was published in the journal Molecular Psychiatry (7). In creat-
ing the TARA intervention, we started by identifying the major 
RDoC domains of function involved in adolescent depression 
and then organized them in a way that gave priority to domains 
thought to be driving the psychopathology. The next step was to 
enhance the translation into an effective clinical intervention for 
adolescent depression. Thus, we integrated approaches from sev-
eral different paradigms and traditions based on their feasibility, 
efficacy and congruence with our neuroscience-based scientific 
theory of change.
Importantly, the DSM diagnostic criteria for adolescent MDD 
have low diagnostic validity and specificity, resulting in unclear 
diagnostic boundaries especially with regard to generalized 
and social anxiety (8–13). As a result, symptoms of generalized 
and social anxiety are highly comorbid with depression symp-
tomatology in this age group (14–17). This has been specifically 
addressed in the DSM5, which states “in terms of genetic risk, 
family, twin, and high-risk transmission studies all indicate that 
Generalized Anxiety Disorder (GAD) and MDD share some, if not 
most, of their genetic risk factors” and a new diagnostic entity of 
mixed depression and anxiety has been introduced. In the RDoC 
matrix, it is also evident that generalized and social anxiety and 
depression symptomatology are linked to dysfunction in the same 
neurocircuitry, such as sustained limbic hyperreactivity (18–20) 
and reduced adaptive flexibility of the default mode network 
(DMN) (20–22). Consequently, we chose to include participants 
with symptoms of depression and/or generalized and social anxi-
ety in this study and hypothesized that the TARA intervention 
should impact both depressive symptomatology and symptoms 
of generalized and social anxiety.
In this pilot study, we aimed to test feasibility, acceptability 
to participants, and clinical plausibility of the TARA interven-
tion before moving on to more intensive neural assessment. As a 
clinically relevant proxy for the hypothesized brain changes that 
we outline below, we used self-reported psychiatric symptom and 
behavioral changes in alignment with the RDoC criteria.
Previous and current fMRI studies from our group and oth-
ers consistently show that depressed adolescents demonstrate 
increased hyperactivation of the amygdala, a key limbic structure 
involved in emotion generative processing (18) and aberrant 
functional connectivity between the amygdala and other 
emotional regulation areas (19, 23, 24). This may be related to 
sustained increase of stress levels with autonomic dysregulation, 
including a sympathetic overdrive and a decreased parasympa-
thetic tone (25, 26). This suggests that vagal afference could be a 
therapeutic possibility (27, 28). We hypothesized that targeting 
the limbic system, by practicing to increase the vagal afference 
by a “bottom-up” approach, could be an effective method to 
treat depression. Maybe specifically so in adolescence, when the 
dorsolateral prefrontal cortex is not yet developed to full adult 
capacity and “top-down” cognitive control is more challenging.
Consequently, the first target of the TARA treatment is to 
increase vagal afference. Based on the literature of respiratory 
limitations: The sample size was small without a control condition. The pilot design 
did not allow for testing the hypothesized brain changes and effect of TARA on relevant 
systemic biomarkers.
conclusion: TARA is feasible in a sample of clinically depressed and/or anxious ado-
lescents and preliminary efficacy was demonstrated by reduced depression and anxiety 
symptoms. The specific symptom and behavioral outcomes corresponded well with the 
hypothesized mechanisms of change.
Keywords: adolescent depression, research Domain criteria (rDoc), non-pharmacological, novel treatment 
development, emotion regulation, autonomic regulation, mindfulness-based, yoga-based
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biofeedback (29–31), autonomic regulation (26), yoga-based 
interventions (32), and vagus nerve stimulation (28), we aimed 
to promote vagal and sensory afference through breathing 
practices and slow synchronized movement during the first 
module (weeks 1–3) (5). We hypothesized that this would cor-
respond to decreased feelings of stress and physical symptoms of 
depression and anxiety (33) in addition to improved emotional 
self-regulatory abilities and sleep.
The second target in TARA is practicing the ability to shift neu-
ral activation away from the DMN, which has been found to be 
significantly altered in fMRI studies of depressed adolescents (34). 
The DMN includes medial cortical structures, such as the ventro-
medial prefrontal cortex and the posterior cingulate cortex, and it 
is critical to negative self-referential processing such as rumina-
tion and worrying known to go awry in depression (35–38). The 
ability to notice when rumination or worrying occurs and then 
consciously switch from this DMN-dominant brain state to one 
focused on present moment sensory awareness has been sug-
gested to have a therapeutic effect in adults with mood disorders 
(39). During the second module (weeks 4–6), TARA participants 
practiced noticing negative self-referential processing and then 
shifting to present moment sensory and interoceptive awareness 
(39–41). By adding practices of identifying, labeling, and express-
ing emotional processes, we hoped to further decrease depressive 
and anxious symptoms (42, 43). The corresponding hypothesized 
outcome was decreased rumination and generalized anxiety.
A large body of literature shows that interpersonal stress and 
social rejection are the strongest proximal risk factors for depres-
sion (44). The third target was therefore to bring the acquired 
skill set into managing of emotions during social interactions, 
which is a relevant real world challenge for many teenagers with 
depressive problems. Recognizing emotional triggers in oneself 
and others, empathetic listening, effective communication, and 
compassionate responses to oneself and others were practiced in 
the third module (weeks 7–9). The corresponding hypothesized 
outcome was decreased social anxiety.
Finally, fMRI studies suggest that regulation of mood states 
depends on interactions, not only as previously described, 
between prefrontal areas and limbic networks, but also between 
the prefrontal areas and striatal nodes (45). Depressed adoles-
cents show disrupted balance of cortico-striatal circuit function, 
with low striatal response and high medial prefrontal response to 
reward (45). A recent diffusion MRI-based study also revealed 
a right caudate-centered sub-network of lower structural con-
nectivity in adolescents with MDD (46). Both acute and chronic 
stress also appears to increase reward deficits, which, in turn, 
raises the risk for depression (47). Due to these findings, the fourth 
target, addressed in the fourth and last module (weeks 10–12), 
was to increase behavioral activation guided by intrinsic reward, 
inspired by techniques in acceptance and commitment therapy 
(48). Here, TARA participants formulated a personal strategy 
for how to live a life aligned with their values, while challenging 
patterns of experiential avoidance, by using practices of top-down 
cognitive control of affective responses. The hypothesized behav-
ioral outcomes were decreased experiential avoidance, increased 
committed action, and improved behavioral effectiveness amidst 
distressing emotional experiences.
In addition to the described neural constructs targeted in 
the development of TARA, contextual factors hypothesized to 
contribute to depressive pathophysiology through increased 
perception of sustained threat were addressed. These included 
discussions about bullying, climate change, and other factors 
about which the participants were concerned (49).
The overall aims for this single-arm pilot study were to test the 
feasibility, acceptability, and preliminary efficacy of the TARA 
intervention in overall reduction of depression and generalized 
and social anxiety symptom scores and to assess whether the 
targeted domains of function were associated with the hypoth-
esized symptom and behavioral changes.
MaTerials anD MeThODs
intervention Format of Tara
The TARA intervention took place over 12 consecutive weekly 
sessions, lasting 90 min each, in a group of up to 12 participants. 
The first session aimed to create a sense of safety by introducing 
the group members; establishing clear guidelines; investigating 
attitudes, opinions, and previous experiences of group processes; 
and introducing contemplative practices. During the sessions, 
participants sat in a circle on yoga mats with the two facilitators 
opposite each other. First, facilitators “opened the circle” by 
ringing a bell and briefly checking-in with everyone. Next, par-
ticipants were guided through 5 min of gentle breathing practices. 
Yoga-based movement followed, consisting of a flow of positions 
synchronized with the breath. Finally, facilitators guided a 
meditation practice that focused mainly on interoceptive and 
sensory awareness that ranged from 1 min in the first session to 
10–15 min duration toward the end of the 12-week intervention 
period. After a short, informal break with snacks, there was time 
for feedback and questions regarding the home practice from the 
previous week. This was followed by a brief psycho-educational 
presentation including small and large group exercises and dis-
cussions. The sessions concluded with the facilitators describing 
the home practices for the coming week and “closing of the circle,” 
when the participants gathered their attention and then had the 
opportunity to name any reflections from the session.
Development of the TARA program was inspired by the 
structure and content of mindfulness-based approaches but is 
fundamentally different in several ways. First, manipulation 
of the breath and synchronized slow movements were used to 
improve emotional self-regulatory skills, rather than a primary 
focus on acceptance of emotional experience through meta-
cognition. There was a focus on “real world” relevance for the 
adolescents, and trans-generational dialog and inquiry were 
emphasized. We also aimed to create full transparency of the 
rationale for each practice, often with a scientific background 
explained in the form of a slide presentation. Participation and 
relational practices were emphasized, as well as practices of vali-
dating and skillfully expressing emotional content. Value-based 
committed action was an extended goal of the curriculum, not 
only equanimity and personal well-being, as is often the case in 
mindfulness-based interventions. Time was spent contextual-
izing depressive symptoms and investigating the negative impact 
that the cultures and systems we live in have on personal health. 
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Home practice of TARA skills was encouraged, with audio tracks 
of breathing instructions and short, guided meditations provided 
to participants.
Facilitator Training and setup
Each class had two facilitators, together covering expertise in con-
templative practices and clinical child psychology or psychiatry. 
The first author, who developed the TARA intervention, observed 
the classes to provide ongoing supervision and training to the 
teachers and monitor fidelity of implementation of the TARA 
protocol, both in terms of content adherence and fidelity to the 
process of delivery of the different modalities of the intervention. 
The emphasis was not only in teaching specific content but also 
in modeling a collaborative, inclusive, non-judgmental, and sup-
portive attitude.
Participants and recruitment
Participants were recruited through the San Francisco United 
School District’s public high school Wellness Centers, commu-
nity sites throughout the San Francisco Bay Area, and through 
fliers and outreach by study staff. In this pilot study, our team 
worked to identify the appropriate inclusion criteria for the 
study, settling on 14- to 18-year-old adolescents still in high 
school, with clinically significant depressive and/or anxious 
symptomatology as measured by the Children’s Depression 
Rating Scale-Revised (CDRS-R >  35) (50, 51) and/or by the 
Multidimensional Anxiety Scale for Children (MASC T-score 
>56) (52), respectively. All participants were required to be 
under the care of a physician or mental health provider. Exclusion 
criteria were mainly conditions that would prevent effective 
group participation, i.e., current comorbidity of psychosis, 
severe anorexia nervosa, acute posttraumatic stress disorder, 
severe self-mutilation, severe suicidal ideation, or any suicide 
attempt in the past 3  months, lifetime comorbidity of bipolar 
disorder, low-functioning autism spectrum disorder, intellec-
tual disability (estimated IQ < 80), and substance dependence. 
We excluded non-English speakers because the TARA groups 
were conducted in English. Individuals with ongoing practice 
of meditation and/or yoga of >20 min two times per week or 
more for the past 2 months were also excluded. One participant, 
with no suicidal ideation at baseline, was permitted to enroll 
in the study despite being treated concurrently with Dialectical 
Behavior Therapy.
All participants provided informed written assent and their 
parent(s)/legal guardian(s) provided informed written consent, 
in accordance with the Declaration of Helsinki. The Human 
Research Protection Program of the University of California San 
Francisco approved all study procedures. Potential participants 
and their parents/guardians (if <18  years old) first completed 
a semi-scripted phone screening, designed to elicit preliminary 
inclusion/exclusion information and to provide additional 
information about TARA. The study procedures were described 
to ensure the candidates understood the commitment involved. 
If they were eligible and still interested, they were scheduled for 
the first intake interview. An interviewer-administered depres-
sion and suicide assessment was then performed, and self-report 
scales for depression and anxiety symptoms, and demographics 
were completed. A diagnostic assessment was administered 
online to rule out comorbidities that would exclude participation.
Immediately prior to the start of the intervention (T0), a base-
line visit was scheduled for participants to complete self-report 
questionnaires. The same assessment was repeated immediately 
after the TARA intervention (T1, 3 months later) and at 6-month 
follow-up from baseline (T2). Participants were also asked to 
complete session-by-session ratings and invited to participate in a 
post TARA focus group to discuss their experience and receptiv-
ity to the TARA intervention with an external interviewer and 
offer suggestions for improvement. The focus group session was 
audio-recorded and then transcribed.
Measures
Primary and Secondary Outcome Measures,  
Self-Report Scales
Reynolds Adolescent Depression Scale Second Edition (RADS-2) 
was the primary depression outcome measure. The RADS-2 has 
excellent psychometric properties and is validated in depressed 
adolescents (53). It contains 30 items, providing 4 subscales 
measuring different dimensions of depression: Dysphoric Mood, 
Anhedonia/Negative Affect, Negative Self-Evaluation, and 
Somatic Complaints. Raw scores range from 30 to 120.
Multidimensional Anxiety Scale for Children (MASC) was 
the primary outcome anxiety measure and was also used to access 
eligibility as it is considered the best normed and psychometrically 
strong self-report anxiety scale for use with adolescents (52). The 
MASC contains 39 items with a total raw score ranging from 0 to 
117. It assesses four dimensions of anxiety: physical symptoms, 
harm/avoidance, social anxiety, and separation/panic.
Insomnia Severity Index (ISI) was a secondary measure and 
is a brief 7-item assessment scale for insomnia (54) with scores 
ranging from 0 to 28.
Child and Adolescent Mindfulness Measure (CAMM) was 
also a secondary measure and is a 10-item self-assessment scale 
based on a Likert scale with possible scores ranging from 1 to 
100, which is shown to have adequate internal consistency and be 
a useful measure of mindfulness skills for school-aged children 
and adolescents (55).
Avoidance and Fusion Questionnaire for Youth (AFQ-Y) was 
the final secondary measure and is an 8-item measure of psycho-
logical inflexibility fostered by (a) cognitive fusion, (b) experien-
tial avoidance, and (c) inaction or behavioral ineffectiveness in 
the presence of unwanted internal experiences (56). Measured on 
a 5-point Likert Scale with possible scores ranging from 0 to 32.
Secondary Outcome Measures, Clinician 
Assessment
Children’s Depression Rating Scale-Revised (CDRS-R) was used 
as a secondary depression outcome and was also used to assess 
study eligibility. It is a standardized rating scale based on a semi-
structured interview and provides an efficient way to diagnose 
childhood depression and monitor treatment response (50). 
Specifically trained staff performed this assessment, and it was 
videotaped for quality control by a child psychiatrist.
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Baseline Assessments
Development and Well-Being Assessment (DAWBA) is an 
Internet-based semi-structured diagnostic interview compat-
ible with the psychiatric diagnostic criteria of the DSM-IV for 
5- to 17-year-old individuals. DAWBA has consistently generated 
sensible estimates of prevalence and association with risk factors 
(57). When compared to clinical diagnoses, DAWBA diagnoses 
have good validity (58). DAWBA is used in large multicenter 
neuroimaging studies in Europe, such as the Imagen study (59).
Columbia Suicidality Severity Rating Scale (CSSRS) was 
used to screen for suicidality. This widely used measure assesses 
the full range of evidence-based suicidal ideation and behavior 
items (60).
Hollingshead Four Factor Index of Socioeconomic Status (61) 
was used to gather data on race, parents’ marital status, employ-
ment status, educational attainment, and occupation.
Childhood Trauma Questionnaire (CTQ) (62) is a 28-item 
self-report scale used to measure history of child abuse and 
neglect. CTQ has dichotomous clinical cutoff scores for the 
five subscales that differentiate between presence or absence of 
significant physical abuse, physical neglect, sexual abuse, emo-
tional abuse, and emotional neglect (63). Reliability and validity 
are well established, and the total CTQ scale is considered 
capable of adequately capturing a broad dimension of childhood 
maltreatment (64).
Monitoring Instruments
The Child Outcome Rating Scale (CORS) and Child Session 
Rating Scale (CSRS) are 4-item self-assessments using a 10-cm 
visual analog scale (65), with higher scores indicating better 
functioning/experience. Participants completed the CORS before 
each session, rating how they had been doing individually, in the 
family, in school, and overall, over the prior week. The CSRS, a 
measure of working alliance, was completed after each session. 
Participants rated the session in terms of how much they felt lis-
tened to, how important the content and activities were to them, 
how much they liked the session, and their overall experience.
statistical Methods
Means and SDs were calculated for each self-report and clini-
cian rating at each time point and calculations were based on 
intended to treat analyses. To assess change in the clinical and 
self-assessment scores from T0 to T1 and from T0 to T2, we 
used hierarchical models of change, including all three time-
points as a linear trend. Effect sizes (ES) were calculated based 
on proportion of variance between T0 and T1 and between T0 
and T2, accounted for by the time effect. Dropouts were defined 
as clinical trial dropouts, i.e., having missed more than 50% of 
the classes. Baseline scores of RADS-2 and MASC were used in 
logistic regression to predict clinical dropout. SAS 9.4 was used 
for all analyses.
resUlTs
attendance and retention
Twenty-six participants (mean age 15.6, range: 14–18  years, 
7 boys and 19 girls) were eligible and enrolled in the TARA 
program in three consecutive groups: the first (Group A, n = 4) 
started in May 2014, the second (Group B, n = 11) in January 
2015, and the third (Group C, n = 11) in April 2015. Groups A 
and B had the same teachers and Group C had a new set of teach-
ers. Two of the participants (8%) missed more than 50% of the 
sessions and the mean attendance rate per session was 78.5% of 
the participants (Figures 1, S1). The mean proportion of sessions 
attended by individual participant was on average 9.5 of the 12 
sessions, i.e. 79.2% of the total sessions (Figures S1, S2).
sample Baseline characteristics
Race and Socioeconomic Status
Our sample contained participants with the following racial 
distribution: White 46%, Hispanic/Latino 15%, Asian 12%, 
Native Hawaiian 4%, African-American 0%, and multiracial 23% 
(Table 1). Parents’ level of education was diverse and ranged from 
one or both parents with less than a high school education (n = 6) 
to both parents completing graduate or professional training 
(n = 13). The majority of participants (n = 23, 88%) had at least 
one employed parent.
Lifetime Trauma Exposure
The baseline CTQ total scores ranged from 36.25 to 96.82, with 
a mean value of 55.79 and SD of 14.39 indicating presence of 
significant lifetime abuse and neglect based on the CTQ cutoffs.
Suicidality
During the CSSRS, four participants reported a lifetime history 
of suicide attempts, two of whom had been psychiatrically hos-
pitalized. Fifteen participants reported a prior history of suicidal 
ideation, and 10 had self-harming behavior. In the 2 weeks prior 
to the baseline interview, seven participants reported experienc-
ing suicidal ideation which was sporadic and not assessed as 
severe, two participants reported self-harming behavior without 
suicidal ideation; no one reported recent suicide attempt. These 
seven participants were not considered fulfilling the exclusion 
criterion of severe suicidal ideation and therefore enrolled in the 
study.
Comorbid Psychiatric Disorders
Based on prior assessment and validation with DAWBA, 17 of the 
participants had a DSM-IV diagnosis of MDD, 14 met criteria 
for a DSM-IV anxiety disorder (AD). Eleven participants had 
comorbidity of both MDD and an AD, and six participants had 
neither a DSM-IV diagnosis of MDD or AD but scored above the 
described cutoff on CDRS-R and/or MASC (Figure S3). In addi-
tion to MDD and/or AD, 2 participants had a comorbid eating 
disorder and 10 had comorbid ADHD.
Concurrent Treatment
Nearly all (88%) of the participants were receiving psycho-
therapy or counseling at the time of TARA enrollment, with 
duration ranging from 2 to 121  months. Seventeen of the 
participants were taking psychotropic medication, which had 
been ongoing for 3–24  months prior to entering the TARA 
program. Twelve participants (46%) were treated with some 
kind of antidepressant medication: 10 with selective serotonin 
FigUre 1 | consort flow diagram showing the recruitment process.
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reuptake inhibitors (sertraline, fluoxetine, and escitalopram), 
two with serotonin–noradrenaline reuptake inhibitors (venla-
faxine and duloxetine), one with a serotonin receptor antagonist 
and reuptake inhibitor (trazodone). In addition, 1 participant 
was treated with a benzodiazepine (clonazepam), 1 with a mood 
stabilizer (lamotrigine), and 10 with central stimulant drugs 
(9  with metylphenidate and one with atomoxetin). Sixteen 
(62%) of the participants had failed to respond to psychological 
treatment for 6 months or more and 5 of the participants (19% 
of the 26 participants) had failed to respond to antidepressant 
medication for 6 months or more.
Group Differences at Baseline
Sample characteristics at baseline in Groups A–C see Table 1.
Primary Outcomes
Depression symptom severity as measured by the RADS-2 total 
T scores showed significant improvement from T0 to T1 with a 
mean difference = −4.21, t-value = −3.56, p = 0.002, ES = 0.53, 
95% confidence interval (95% CI): −6.64 to −1.77 and T0–T2 
with a mean difference = −7.48, t-value = −4.17, p <  0.001, 
ES  =  0.83, 95% CI: −11.20 to −3.75. Anxiety symptoms as 
measured by MASC between T0 and T1 showed mean differ-
ence = −2.41, t-value = −2.26, p =  0.033, ES =  0.20, 95% CI: 
−4.61 to −0.21 and between T0 and T2 mean difference = −5.37, 
t-value = −3.06, p =  0.006, 95% ES =  0.38 CI: −9.02 to 1.73 
(Table  2; Figures  2A,B). The RADS-2 subscale Negative Self-
Evaluation showed the biggest ES of 0.87 between T0 and T2. 
Total T score of RADS-2 and MASC at baseline did not predict 
dropout during the TARA intervention.
secondary Outcomes
Interviewer assessed depression symptom severity by CDRS-R 
followed a similar but weaker pattern as the RADS-2. Between 
T0 and T1, a difference of mean score = −2.73, t-value = −1.81, 
p = 0.08, ES = 0.17, 95% CI −5.84 to 0.38; and from T0 to T2, a 
difference of mean score −6.13, t-value −3.51, p = 0.002, 95% CI: 
−9.78 to −2.48. Insomnia measured with ISI and mindfulness 
skills measured by the CAMM did not improve significantly dur-
ing the intervention (T0−T1), but improved significantly when 
including the 3-month follow-up (T0–T2). ISI showed difference 
of mean scores T0–T2 of −4.28, t-value −3.6, p ≤ 0.002, 95% CI: 
−6.77 to −1.80. ISI was only used in Groups B and C. CAMM 
showed a difference of mean scores T0–T2 of 4.36, t-value = 3.89, 
p ≤ 0.001, 95% CI: 2.03 to 6.68. Psychological flexibility measured 
with AFQ-Y improved significantly during the TARA interven-
tion and showed a change in mean scores from T0 to T1 of −6.50, 
t = −2.83, p = 0.0094, 95% CI and continued to improve slightly 
after the intervention was completed, delta = −7.00, t = −2.11, 
TaBle 1 | Baseline sample characteristics of the three groups a–c of 
Training for Awareness, Resilience, and Action (Tara), including mean 
total T scores and sD of self-assessment with reynolds adolescent 
Depression scale second edition (raDs-2) and Multidimensional anxiety 
scale for children (Masc), mean scores and sD of avoidance and Fusion 
Questionnaire for Youth (aFQ-Y), insomnia severity index (isi), the child 
and adolescent Mindfulness Measure (caMM), interview assessment 
with children’s Depression rating scale-revised (cDrs-r), and finally 
socio-demographic data gathered by hollingshead Four Factor index of 
socioeconomic status.
sample characteristics group a 
n = 4
group B 
n = 11
group c  
n = 11
Mean score 
(sD)
Mean score 
(sD)
Mean score 
(sD)
RADS-2 total T score 68.0 (8.68) 65.4 (11.07) 57.3 (9.17)
MASC total T score 59.5 (2.65) 71.9 (9.16) 59.5 (9.33)
ISI – 14.8 (5.83) 6.8 (4.94)
CAMM 28.8 (3.87) 24.4 (6.09) 30.7 (8.79)
AFQ-Y 48.0 (19.6) 53.1 (15.3) 40.7 (13.6)
CDRS-R 70.5 (10.27) 68.0 (8.54) 63.8 (2.82)
Ratio boys/girls 2/2 1/10 4/7
Both parents born in US 2/4 8/11 8/11
Participant born in US 4/4 10/11 11/11
Race: White/Hispanic/Asian/
African-American/Multiracial
2/0/1/0/1 3/4/2/0/2 7/0/0/0/3 + 1 
Native Hawaiian
Lives with biological father 
and/or mother
3/4 10/11 9/11
Parents’ divorced 2/4 3/11 5/11
Parents’ educational level 
was post high school
0/4 5/11 7/11
Mean household income, 
USD/year (range)
35,000 
(<10,000–
80,000)
125,000 
(<10,000–
500,000)
96,000  
(35,000– 
450,000)
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p = 0.047, 95% CI (Table 2; Figures 2C–F). ES for the a priori 
hypothesized specific proxy outcomes related to target 1–4, see 
Table 3.
Medication changes
No changes of medications were made as part of the TARA 
protocol. No participants added additional antidepressant 
or stimulant medications during TARA. Discontinuations of 
medication during TARA were reported, and whether this was 
related to TARA is uncertain. Three of the 17 participants who 
were taking antidepressant medication at T0 stopped taking this 
medication by T2 and one had reduced the number of antide-
pressant medications from 2 to 1. Two participants had stopped 
taking stimulant medication at T2. Some additional information 
with regard to the discontinuation of medication was obtained at 
the T2 interview. One participant had lost her medication during 
the summer holiday and in the T2 interview she said it was likely 
she would begin taking the medication again, but it is unknown 
whether she did. Another participant never took her medication 
during summer holiday and planned to begin again when school 
started.
Monitoring assessment
The Children’s Outcome Rating Scale (CORS) indicated an over-
all improvement in well-being over the course of the intervention, 
with participant mean score increasing from 21.1 to 30.6 (out of 
maximum 40) from session 1 to 12. This measure was intended 
as a monitoring instrument to identify unexpected decreases 
in well-being during the intervention and not as an outcome 
measure and therefore was not further analyzed. The Children’s 
TaBle 2 | Difference in mean scores, t-values, p-values, and 95% confidence interval (95% ci) between pre-Training for Awareness, Resilience, and 
Action (Tara) (T0) and post-Tara (T1) and between T0 and 3 months after the end of Tara (T2).
T0 baseline–T1 post-Tara (immediate post-
intervention; 3 months after study entry)
T0 baseline–T2 post-Tara (3-month post-
intervention follow-up; 6 months after study entry)
Variable Difference t (df = 24) p 95% ci Difference t (df = 21) p 95% ci
RADS-2 total −4.21 −3.56 0.002 (−6.64, −1.77) −7.48 −4.17 <0.001 (−11.20, −3.75)
RADS-2 anhedonia/negative affect −4.50 −2.54 0.018 (−8.15, −0.85) −5.99 −2.37 0.027 (−11.23, −0.74)
RADS-2 dysphoric mood −2.17 −1.45 0.160 (−5.26, 0.92) −5.81 −2.84 <0.010 (−10.06, −1.56)
RADS-2 negative self-evaluation −4.85 −3.81 <0.001 (−7.47, −2.22) −7.28 −4.17 <0.001 (−10.92, −3.65)
RADS-2 somatic complaints −2.13 −1.88 0.073 (−4.48, 0.21) −5.14 −3.92 <0.001 (−7.88, −2.41)
MASC total −2.41 −2.26 0.033 (−4.61, −0.21) −5.37 −3.06 0.006 (−9.02, −1.73)
MASC physical symptoms −0.52 −0.37 0.714 (−3.40, 2.36) −3.81 −2.03 0.056 (−7.71, 0.10)
MASC harm/avoidance −0.20 −0.12 0.902 (−3.58, 3.18) 1.05 0.44 0.667 (−3.96, 6.06)
MASC social anxiety −3.76 −2.82 0.010 (−6.51, −1.00) −5.04 −3.63 0.002 (−7.93, −2.15)
MASC separation/panic −2.16 −2.03 0.054 (−4.35, 0.04) −6.33 −3.13 0.005 (−10.52, −2.13)
ISI −0.42 −0.44 0.665 (−2.40, 1.56) −4.28 −3.60 0.002 (−6.77, −1.80)
CAMM 0.84 0.68 0.504 (−1.72, 3.40) 4.36 3.89 <0.001 (2.03, 6.68)
AFQ-Y −6.50 −2.83 0.009 (−11.24, −1.75) −7.00 −2.11 0.047 (−13.91, −0.09)
CDRS-R −2.73 −1.81 0.082 (−5.84, 0.38) −6.13 −3.51 0.002 (−9.78, −2.48)
The measures reported are Reynolds Adolescent Depression Scale Second Edition (RADS-2), total T scores, and the subscales anhedonia/negative affect, dysphoric mood, 
negative self-evaluation, somatic complaints; Multidimensional Anxiety Scale for Children (MASC) total T scores, and the subscales physical symptoms, harm/avoidance, social 
anxiety, separation/panic; Insomnia Severity Index (ISI); Child and Adolescent Mindfulness Measure (CAMM); Avoidance and Fusion Questionnaire for Youth (AFQ-Y); interview 
assessment with Children’s Depression Rating Scale-Revised (CDRS-R).
FigUre 2 | (a–F) Self-assessment mean results pre-Training for Awareness, Resilience, and Action (TARA) (T0), post-TARA (T1), and at 3-month follow-up after 
TARA (T2). Note that the y-axis in Panel (a,B,F) range from 40 to 70. (a) Depression symptoms with Reynolds Adolescent Depression Scale Second Edition 
(RADS-2), total T scores. (B) Anxiety symptoms with Multidimensional Anxiety Scale for Children (MASC), total T scores. (c) Insomnia with Insomnia Severity Index 
(ISI), total scores. (D) Emotional self-regulation and “mindfulness skills” with the Child and Adolescent Mindfulness Measure (CAMM), total score. (e) Avoidance and 
Fusion Questionnaire for Youth (AFQ-Y) total scores. (F) Clinician assessed Children’s Depression Rating Scale-Revised (CDRS-R).
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Session Rating Scale (CSRS), which was administered after every 
session, reflected overall satisfaction with the content with a mean 
total score of 33.5 out of maximum 40. During sessions 1–12, the 
CSRS scores ranged from 25.9 to 37.3.
Qualitative Data from Focus group 
interviews
All participants were invited to the focus group interview with a 
trained interviewer that took place shortly after the last session. 
Many participants reported that they had chosen to participate 
in TARA because it was different from the “talk-therapy,” which 
they already had experienced. Participants reported that they 
liked the diversity of activities and skills taught in the classes, 
with some who specifically enjoyed the yoga-based movement. 
Some of the participants valued the opportunity to meet teens 
in similar situations as themselves. In general, they perceived the 
group as a safe place where they felt listened to and respected. 
They reported liking the format, duration, and frequency of the 
sessions and wanted more interactive practices and discussions. 
Most participants said that they especially found the breathing 
exercises helpful, that they practiced these outside of class and 
TaBle 3 | number of participants, means, sDs of assessments, and effect sizes (es) calculated as proportion of variance pre-Training for Awareness, 
Resilience, and Action (Tara) (T0), post-Tara (T1), and at 3 months after the end of Tara (T2).
T0 N = 26 T1 N = 25 T2 N = 22 es (proportion of variance) es (proportion of variance)
Mean (sD) Mean (sD) Mean (sD) T0–T1 T0–T2
RADS-2 total T scores 62.35 (10.59) 57.92 (9.50) 54.05 (9.94) 0.53 0.83
RADS-2 anhedonia/negative affect 58.96 (13.06) 54.52 (11.92) 52.18 (12.23) 0.27 0.27
RADS-2 dysphoric mood 60.50 (9.88) 58.08 (8.03) 54.27 (9.38) 0.09 0.39
RADS-2 negative self-evaluation 61.35 (11.65) 56.12 (9.02) 52.82 (8.97) 0.61 0.83
RADS-2 somatic complaints 59.62 (9.34) 57.44 (8.94) 54.27 (10.15) 0.15 0.73
MASC total T scores 64.73 (10.42) 62.28 (9.83) 59.77 (9.87) 0.21 0.45
MASC physical symptoms 58.07 (12.57) 57.36 (12.21) 54.68 (11.84) 0.01 0.20
MASC harm avoidance 54.12 (9.55) 53.80 (8.24) 55.05 (10.35) 0.00 0.01
MASC social anxiety 68.77 (7.45) 65.24 (10.84) 64.27 (9.81) 0.33 0.63
MASC separation panic 59.81 (11.22) 57.68 (10.35) 53.95 (9.53) 0.17 0.47
ISI N = 21 10.82 (6.67) N = 21 10.62 (6.82) N = 20 6.68 (5.43) 0.01 0.67
CAMM 27.7 (7.53) 28.52 (9.24) 32.06 (7.23) 0.02 0.72
AFQ-Y 16.18 (7.17) 13.91 (7.68) 13.05 (7.68) 0.33 0.21
CDRS-R 66.62 (7.20) 63.92 (9.27) 60.65 (8.01) 0.17 0.38
The measures reported are Reynolds Adolescent Depression Scale Second Edition (RADS-2) total T scores, Multidimensional Anxiety Scale for Children (MASC) total T scores, 
Insomnia Severity Index (ISI), Child and Adolescent Mindfulness Measure (CAMM), Avoidance and Fusion Questionnaire for Youth (AFQ-Y), and interview assessment with Children’s 
Depression Rating Scale-Revised (CDRS-R).
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reported benefits in terms of anxiety- and stress reduction, as 
well as improved sleep. Participants reported that they gradually 
became more appreciative of doing practices in silence over the 
12 weeks. Some of the participants were less enthusiastic about 
the presentation of the scientific rationale, while others found this 
educational component specifically helpful.
DiscUssiOn
This single-arm pilot study was conducted to test the feasibility, 
acceptability, and preliminary efficacy of a novel treatment for 
adolescent depression, TARA. We found that TARA was feasible 
and acceptable in terms of study retention (84.6%), attendance 
rates (in average 9.5/12 sessions), and from positive post-TARA 
focus group feedback regarding the structure and content of 
the program. The results demonstrated preliminary efficacy of 
the TARA program in improving symptoms of depression and 
generalized and social anxiety. Importantly, these symptoms 
continued to improve after the program, suggesting successful 
acquisition and retention of adequate emotion regulation skills 
and a willingness to use the practices in daily life after the TARA 
program ended.
The specific aim of this study was to test the scientific hypoth-
eses regarding the targeted neural mechanisms of change in the 
four modules of TARA, using specific symptom and behavioral 
indicators as clinically relevant proxies. We assessed the change in 
outcome measures from baseline (T0) to post-intervention (T1) 
and from baseline to 6-month follow-up (T2).
The strategy to impact the first target of amygdala hyperreactiv-
ity was to promote vagal and sensory afference through breathing 
practices and slow synchronized movement. We hypothesized 
that this would correspond to a decrease of somatic and vegetative 
symptoms of depression and improved self-regulatory skills and 
sleep. These symptoms are also common in generalized forms of 
anxiety including stomach aches, feeling ill, fatigue, insomnia, or 
other sleep disturbances. These symptoms are well defined in the 
somatic complaints subscale of RADS-2. We found preliminary 
evidence that this first target of sustained amygdala hyperre-
activity was influenced through the intervention, based on the 
decrease the scores of RADS-2 Somatic Complaints subscale, as 
well as on the improvement of self-regulatory skill measured by 
CAMM, and reduced insomnia measured with ISI (Table 2). It 
may be noted that the MASC subscale Physical Symptoms cap-
tures symptoms that are more common in acute forms of anxiety 
such as panic attacks or specific phobias, including feeling tense 
or restless, having trouble breathing, feeling dizzy, having sweaty 
or cold hands, being shaky or jittery. These symptoms belong 
to the RDoC construct of acute threat and were not targeted 
in the TARA program. Similarly, the symptoms assessed in the 
MASC subscales of panic or harm/avoidance were not specifically 
targeted in TARA and did not show significant change pre- com-
pared to post-intervention. These findings support the specificity 
of the TARA intervention in reducing symptoms relevant to the 
first target—the sustained limbic hyperreactivity.
Our strategy to impact the second target, inflexibility in the 
ability to shift neural activity away from DMN, was to practice 
noticing negative self-referencing processing and then con-
sciously shifting to present moment sensory and interoceptive 
awareness. We hypothesized that this would decrease rumination 
as measured by RADS-2 Negative Self-Evaluation, which was 
supported in the study.
The third target, interpersonal stress and social anxiety, was 
addressed by bringing the acquired skillset of emotion regula-
tion from modules 1 to 2 into the context of social interaction. 
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Participants practiced labeling and expressing emotions, 
identifying emotional triggers, empathetic listening, and a 
compassionate response to oneself and others. We hypothesized 
that these practices would result in a decrease of social anxiety, 
which was supported by significant changes in the MASC sub-
scale Social Anxiety. It should be pointed out that social anxiety 
has not been considered as a potential confounding factor for 
changes in depression symptom severity pre- compared to post-
TARA, but rather as an expression of a dysfunction in the same 
RDoC construct, here being expressed within the same unit of 
analysis.
The fourth target was to strengthen cognitive control by intro-
ducing behavioral activation guided by intrinsic reward. During 
the fourth module, time was allocated to defining a life purpose, 
and discussions and practices were aimed at both learning how to 
stay on a trajectory toward this purpose and challenging patterns 
of experiential avoidance by top-down cognitive control over 
affective responses. The preliminary efficacy of module four was 
less evident compared to previous modules. The change in scores 
pre- to post TARA of the Anhedonia Subscale of RADS-2 and 
of AFQ-Y, which measures experiential avoidance, committed 
action and behavioral effectiveness in the presence of distressing 
emotional experiences, were statistically significant, but showed 
smaller effect sizes. We speculate that this may be explained by 
the reduced time allocated for these practices, because they were 
introduced toward the end of the curriculum, in session 10.
In summary, this detailed breakdown of symptoms and behav-
ioral outcomes allowed us to investigate the question of whether 
we were effectively targeting mechanisms relevant to clinical 
improvement of adolescent depressive symptoms. Our results 
provide initial support for three of the targets, with large effects 
observed for physical symptoms of depression, insomnia, nega-
tive self-referential processing, and social anxiety. The last target 
of cognitive control may have had insufficient time allocated in 
the curriculum.
The qualitative data obtained from the focus group suggest 
that the participants perceive that they were helped by the self-
regulatory practices and that they continued to practice after the 
TARA program ended. This may help prevent future recurrent 
episodes of depression. The CSRS showed that participants gener-
ally thought the content of the sessions was relevant and important. 
The gradual improvement of emotional well-being measured at 
each session with the CORS also supports the progression of skills 
uptake over the 12 weeks of active TARA intervention.
It has been suggested that amygdala hyperreactivity could 
be a mediator between adverse childhood experiences and the 
development of emotional disorders (66). We conducted baseline 
assessment of early trauma (CTQ) and verified a positive cor-
relation between CTQ and depression symptoms (RADS-2) at 
baseline (r = 0.52, p < 0.01), which has been consistently found 
in previous studies (33, 67). However, CTQ at baseline was not 
correlated with reduction of RADS-2 scores from T0 to T2, sug-
gesting that childhood trauma did not moderate the effect of the 
TARA treatment in reducing depression symptoms.
Our pilot study had several limitations. First, the sample size 
was small and we had no control condition. The TARA interven-
tion was developed on the basis of fMRI findings of adolescent 
depression within the framework of the NIMH RDoC criteria 
and this pilot study could not directly test our hypothesis of 
brain change. The size of the Groups A–C varied and the teachers 
differed in Groups A and B versus C. The study design did not 
allow us to fully assess whether this had an impact on the TARA 
outcomes. We did not fully assess the frequency and duration of 
the home practice, which would have been interesting to relate 
to the outcome.
A proof-of-concept MRI study to more directly test our 
hypothesis of brain changes is ongoing and if the hypotheses 
are shown valid a next step would be to conduct a well-powered 
randomized controlled trial, preferably with an active control 
condition. We are continuously collecting additional qualitative 
data from new focus groups, to allow more in depth analyses 
and a deeper qualitative assessment of our work. Since the group 
format of focus group interviews may allow for a possible influ-
ence of opinions, within the group of participants, we are also, 
in future TARA groups, adding qualitative assessment by an 
observer blinded to the nature of the intervention attending the 
full scope of classes. In these future groups, we also intend adding 
separate post-TARA interviews of the parents/legal guardians of 
the participants. We hope this may lead to further refinement 
of the TARA manual, including the allocation of more time 
to module four targeting cognitive control, as well as parental 
education groups to support the participants between sessions. 
Additionally, we are currently working on a systematic teacher 
training protocol to manage larger studies.
In conclusion, we demonstrated that the neuroscientifically 
based TARA program was both feasible and acceptable in a sam-
ple of clinically depressed and/or anxious adolescents and could 
be delivered with fidelity. We established preliminary efficacy as 
indicated by improvement of depression symptom and social 
anxiety scores pre- to post-TARA, importantly also in cases 
that had not responded to SSRIs and/or psychological treatment 
for more than 6 months prior to entering the TARA program. 
Furthermore, the participants showed maintained reduction in 
depressive symptoms and social anxiety 3  months after TARA 
ended, suggesting maintained skills after the program had ended. 
We also showed that the specific symptom and behavioral out-
comes corresponded well with the hypothesized mechanisms of 
change.
We acknowledge the complexities of RDoC-based translational 
research and hope this article may be useful as a template for 
helping others apply RDoC-based theories in the development of 
clinical applications and thereby provide patients suffering from 
psychiatric disorders with targeted and more effective treatments.
aUThOr cOnTriBUTiOns
Designed and developed the TARA program: EH. Designed the 
study: EH, LD, FH, PM, TY, TH, MC, and HW. Performed data 
acquisition: EH, VG, PM, and LB. Ethical considerations: EH, 
PM, LD, TY, and FH. Performed data cleaning and analyses: EH, 
MC, VG, and MA. Interpreted and framed the qualitative data: 
EH, MC, TY, and LB. Interpreted the data: EH, OT, TH, MA, MC, 
FH, and TY. Literature review: EH, OT, TH, and CC. Wrote the 
paper: EH, OT, TH, CC, MC, FH, and TY.
11
Henje Blom et al. TARA: RDoC-Based Adolescent Depression Treatment
Frontiers in Psychiatry | www.frontiersin.org January 2017 | Volume 7 | Article 208
acKnOWleDgMenTs
The authors would like to thank all the adolescents who 
participated in the study and Catherine Shaddix, Jonathan 
Weinstock, Niki Berkowitz, and Jonathan Weisblatt for valuable 
feedback and the many hours of preparing and teaching the 
TARA classes. They also appreciate the research assistance of 
Bonnie Chu.
FUnDing
This study was financially supported by the Swedish Research 
Council 3502012303 to EH; by UCSF Research Allocation 
Program (RAP) for Integrative Medicine to LD, FH, TY, and 
EH; by REAC and J. Jacobson Fund to OT, EH, and TY; by 
NCCIH R21AT009173 to OT, TY, and EH; by the Mental Insight 
Foundation to LD, FH, TY, and EH; by the American Foundation 
for Suicide Prevention PDF106413 to TH; by NSF Integrative 
Graduate Education and Research; by NIMH 7R01MH085734, 
3R01MH085734-02-S1, and R01MH085734-05-S1 to TY; by 
NCCIH K01 AT005270 to LD; by NCCIH K24 AT007827 to FH; 
and by the Brain and Behavior Research Foundation (formerly 
NARSAD) to TY. The content is solely the responsibility of the 
authors and does not necessarily represent the official views of 
the National Institutes of Health of other funding agencies. The 
funding agencies did not play any role in study design; in the col-
lection, analysis, and interpretation of data; in the writing of the 
report; and in the decision to submit the article for publication.
sUPPleMenTarY MaTerial
The Supplementary Material for this article can be found online 
at http://journal.frontiersin.org/article/10.3389/fpsyt.2016.00208/
full#supplementary-material.
reFerences
1. Lepine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis 
Treat (2011) 7(Suppl 1):3–7. doi:10.2147/ndt.s19617
2. Avenevoli S, Swendsen J, He JP, Burstein M, Merikangas KR. Major depression 
in the national comorbidity survey-adolescent supplement: prevalence, cor-
relates, and treatment. J Am Acad Child Adolesc Psychiatry (2015) 54(1):37–44.
e2. doi:10.1016/j.jaac.2014.10.010 
3. Birmaher B, Arbelaez C, Brent D. Course and outcome of child and adoles-
cent major depressive disorder. Child Adolesc Psychiatr Clin N Am (2002) 
11(3):619–37. doi:10.1016/S1056-4993(02)00011-1 
4. Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in 
children and adolescents: a meta-analysis. Psychol Bull (2006) 132(1):132–49. 
doi:10.1037/0033-2909.132.1.132 
5. Henje Blom E, Duncan LG, Ho TC, Connolly CG, LeWinn KZ, Chesney M, 
et al. The development of an RDoC-based treatment program for adolescent 
depression: “Training for Awareness, Resilience, and Action” (TARA). Front 
Hum Neurosci (2014) 8:630. doi:10.3389/fnhum.2014.00630
6. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research 
Domain Criteria (RDoC): toward a new classification framework for research 
on mental disorders. Am J Psychiatry (2010) 167(7):748–51. doi:10.1176/ 
appi.ajp.2010.09091379 
7. Alexopoulos GS, Arean P. A model for streamlining psychotherapy in 
the RDoC era: the example of ‘engage’. Mol Psychiatry (2014) 19(1):14–9. 
doi:10.1038/mp.2013.150 
8. Korczak DJ, Goldstein BI. Childhood onset major depressive disorder: course 
of illness and psychiatric comorbidity in a community sample. J Pediatr (2009) 
155(1):118–23. doi:10.1016/j.jpeds.2009.01.061 
9. Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and 
development of psychiatric disorders in childhood and adolescence. Arch Gen 
Psychiatry (2003) 60(8):837–44. doi:10.1001/archpsyc.60.8.837 
10. Ford T, Goodman R, Meltzer H. The British Child and Adolescent Mental Health 
Survey 1999: the prevalence of DSM-IV disorders. J Am Acad Child Adolesc 
Psychiatry (2003) 42(10):1203–11. doi:10.1097/00004583-200310000-00011 
11. Alexandrino-Silva C, Wang YP, Carmen Viana M, Bulhoes RS, Martins SS, 
Andrade LH. Gender differences in symptomatic profiles of depression: 
results from the Sao Paulo Megacity Mental Health Survey. J Affect Disord 
(2013) 147(1–3):355–64. doi:10.1016/j.jad.2012.11.041 
12. Schuch JJ, Roest AM, Nolen WA, Penninx BW, de Jonge P. Gender differ-
ences in major depressive disorder: results from the Netherlands study of 
depression and anxiety. J Affect Disord (2014) 156:156–63. doi:10.1016/j.
jad.2013.12.011 
13. Blom EH, Forsman M, Yang TT, Serlachius E, Larsson JO. Latent classes 
of symptoms related to clinically depressed mood in adolescents. Scand 
J Child Adolesc Psychiatr Psychol (2014) 2(1):19–28. doi:10.21307/sjcapp- 
2014-004 
14. Hettema JM. What is the genetic relationship between anxiety and depression? 
Am J Med Genet C Semin Med Genet (2008) 148C(2):140–6. doi:10.1002/
ajmg.c.30171 
15. Middeldorp CM, Cath DC, Van Dyck R, Boomsma DI. The co-morbidity of 
anxiety and depression in the perspective of genetic epidemiology. A review 
of twin and family studies. Psychol Med (2005) 35(5):611–24. 
16. Spencer TJ. ADHD and comorbidity in childhood. J Clin Psychiatry (2006) 
67(Suppl 8):27–31. 
17. Angold A, Costello EJ. Depressive comorbidity in children and adolescents: 
empirical, theoretical, and methodological issues. Am J Psychiatry (1993) 
150(12):1779–91. doi:10.1176/ajp.150.12.1779 
18. Yang TT, Simmons AN, Matthews SC, Tapert SF, Frank GK, Max JE, et al. 
Adolescents with major depression demonstrate increased amygdala activa-
tion. J Am Acad Child Adolesc Psychiatry (2010) 49(1):42–51. doi:10.1016/ 
j.jaac.2009.09.004 
19. Perlman G, Simmons AN, Wu J, Hahn KS, Tapert SF, Max JE, et al. Amygdala 
response and functional connectivity during emotion regulation: a study of 
14 depressed adolescents. J Affect Disord (2012) 139(1):75–84. doi:10.1016/ 
j.jad.2012.01.044 
20. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain’s default network: 
anatomy, function, and relevance to disease. Ann N Y Acad Sci (2008) 
1124:1–38. doi:10.1196/annals.1440.011 
21. Greicius M. Resting-state functional connectivity in neuropsychiatric disorders. 
Curr Opin Neurol (2008) 21(4):424–30. doi:10.1097/WCO.0b013e328306f2c5 
22. Hamilton JP, Chen MC, Gotlib IH. Neural systems approaches to under-
standing major depressive disorder: an intrinsic functional organization 
perspective. Neurobiol Dis (2013) 52:4–11. doi:10.1016/j.nbd.2012.01.015 
23. Connolly CG, Wu J, Ho TC, Hoeft F, Wolkowitz O, Eisendrath S, et  al. 
Resting-state functional connectivity of subgenual anterior cingulate cortex 
in depressed adolescents. Biol Psychiatry (2013) 74(12):898–907. doi:10.1016/ 
j.biopsych.2013.05.036 
24. Cullen KR, Westlund MK, Klimes-Dougan B, Mueller BA, Houri A, Eberly 
LE, et  al. Abnormal amygdala resting-state functional connectivity in ado-
lescent depression. JAMA psychiatry (2014) 71(10):1138–47. doi:10.1001/
jamapsychiatry.2014.1087 
25. Thayer JF, Sternberg E. Beyond heart rate variability: vagal regulation of 
allostatic systems. Ann N Y Acad Sci (2006) 1088:361–72. doi:10.1196/
annals.1366.014 
26. Henje Blom E, Olsson EM, Serlachius E, Ericson M, Ingvar M. Heart 
rate variability (HRV) in adolescent females with anxiety disorders 
and major depressive disorder. Acta Paediatr (2010) 99(4):604–11. 
doi:10.1111/j.1651-2227.2009.01657.x 
27. Thayer JF. Vagal tone and the inflammatory reflex. Cleve Clin J Med (2009) 
76(Suppl 2):S23–6. doi:10.3949/ccjm.76.s2.05 
28. Park MC, Goldman MA, Carpenter LL, Price LH, Friehs GM. Vagus nerve 
stimulation for depression: rationale, anatomical and physiological basis of 
12
Henje Blom et al. TARA: RDoC-Based Adolescent Depression Treatment
Frontiers in Psychiatry | www.frontiersin.org January 2017 | Volume 7 | Article 208
efficacy and future prospects. Acta Neurochir Suppl (2007) 97(Pt 2):407–16. 
doi:10.1007/978-3-211-33081-4_46 
29. Henje Blom E, Serlachius E, Chesney MA, Olsson EM. Adolescent girls with 
emotional disorders have a lower end-tidal CO2 and increased respiratory 
rate compared with healthy controls. Psychophysiology (2014) 51(5):412–8. 
doi:10.1111/psyp.12188 
30. Karavidas MK, Lehrer PM, Vaschillo E, Vaschillo B, Marin H, Buyske S, et al. 
Preliminary results of an open label study of heart rate variability biofeedback 
for the treatment of major depression. Appl Psychophysiol Biofeedback (2007) 
32(1):19–30. doi:10.1007/s10484-006-9029-z 
31. Patron E, Messerotti Benvenuti S, Favretto G, Valfre C, Bonfa C, Gasparotto 
R, et  al. Biofeedback assisted control of respiratory sinus arrhythmia as a 
biobehavioral intervention for depressive symptoms in patients after cardiac 
surgery: a preliminary study. Appl Psychophysiol Biofeedback (2013) 38(1):1–9. 
doi:10.1007/s10484-012-9202-5
32. Schmalzl L, Powers C, Henje Blom E. Neurophysiological and neurocognitive 
mechanisms underlying the effects of yoga-based practices: towards a compre-
hensive theoretical framework. Front Hum Neurosci (2015) 9:235. doi:10.3389/
fnhum.2015.00235 
33. Gulec MY, Altintas M, Inanc L, Bezgin CH, Koca EK, Gulec H. Effects of 
childhood trauma on somatization in major depressive disorder: the role of 
alexithymia. J Affect Disord (2013) 146(1):137–41. doi:10.1016/j.jad.2012. 
06.033 
34. Ho TC, Connolly CG, Henje Blom E, LeWinn KZ, Strigo IA, Paulus MP, et al. 
Emotion-dependent functional connectivity of the default mode network 
in adolescent depression. Biol Psychiatry (2015) 78(9):635–46. doi:10.1016/ 
j.biopsych.2014.09.002 
35. Spreng RN, Mar RA, Kim AS. The common neural basis of autobiograph-
ical memory, prospection, navigation, theory of mind, and the default 
mode: a quantitative meta-analysis. J Cogn Neurosci (2009) 21(3):489–510. 
doi:10.1162/jocn.2008.21029 
36. Hamilton JP, Furman DJ, Chang C, Thomason ME, Dennis E, Gotlib IH. 
Default-mode and task-positive network activity in major depressive disorder: 
implications for adaptive and maladaptive rumination. Biol Psychiatry (2011) 
70(4):327–33. doi:10.1016/j.biopsych.2011.02.003 
37. Berman MG, Peltier S, Nee DE, Kross E, Deldin PJ, Jonides J. Depression, 
rumination and the default network. Soc Cogn Affect Neurosci (2011) 
6(5):548–55. doi:10.1093/scan/nsq080 
38. Bargh JA, Tota ME. Context-dependent automatic processing in depression: 
accessibility of negative constructs with regard to self but not others. J Pers Soc 
Psychol (1988) 54(6):925–39. doi:10.1037/0022-3514.54.6.925 
39. Farb NA, Anderson AK, Segal ZV. The mindful brain and emotion regulation 
in mood disorders. Can J Psychiatry (2012) 57(2):70–7. 
40. Farb NA, Segal ZV, Mayberg H, Bean J, McKeon D, Fatima Z, et al. Attending 
to the present: mindfulness meditation reveals distinct neural modes of 
self-reference. Soc Cogn Affect Neurosci (2007) 2(4):313–22. doi:10.1093/scan/
nsm030 
41. Taylor VA, Daneault V, Grant J, Scavone G, Breton E, Roffe-Vidal S, et  al. 
Impact of meditation training on the default mode network during a 
restful state. Soc Cogn Affect Neurosci (2013) 8(1):4–14. doi:10.1093/scan/ 
nsr087 
42. Creswell JD, Way BM, Eisenberger NI, Lieberman MD. Neural correlates 
of dispositional mindfulness during affect labeling. Psychosom Med (2007) 
69(6):560–5. doi:10.1097/PSY.0b013e3180f6171f 
43. Lieberman MD, Eisenberger NI, Crockett MJ, Tom SM, Pfeifer JH, 
Way BM. Putting feelings into words: affect labeling disrupts amygdala 
activity in response to affective stimuli. Psychol Sci (2007) 18(5):421–8. 
doi:10.1111/j.1467-9280.2007.01916.x 
44. Slavich GM, Irwin MR. From stress to inflammation and major depressive 
disorder: a social signal transduction theory of depression. Psychol Bull (2014) 
140(3):774–815. doi:10.1037/a0035302 
45. Forbes EE, Dahl RE. Research review: altered reward function in adolescent 
depression: what, when and how? J Child Psychol Psychiatry (2012) 53(1):3–15. 
doi:10.1111/j.1469-7610.2011.02477.x 
46. Tymofiyeva O, Connolly CG, Ho TC, Sacchet MD, Henje Blom E, LeWinn KZ, 
et al. DTI-based connectome analysis of adolescents with major depressive 
disorder reveals hypoconnectivity of the right caudate. J Affect Disord (2017) 
207:18–25. doi:10.1016/j.jad.2016.09.013 
47. Auerbach RP, Admon R, Pizzagalli DA. Adolescent depression: stress and 
reward dysfunction. Harv Rev Psychiatry (2014) 22(3):139–48. doi:10.1097/
HRP.0000000000000034 
48. Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and com-
mitment therapy: model, processes and outcomes. Behav Res Ther (2006) 
44(1):1–25. doi:10.1016/j.brat.2005.06.006 
49. Henje Blom E, Ho TC, Connolly CG, LeWinn KZ, Sacchet MD, Tymofiyeva 
O, et al. The neuroscience and context of adolescent depression. Acta Paediatr 
(2016) 105(4):358–65. doi:10.1111/apa.13299 
50. Poznanski EO. Children’s Depression Rating Scale-Revised (CDRS-R) Manual. 
Los Angeles: Western Psychological Services (1996). 76 p.
51. Guo Y, Nilsson ME, Heiligenstein J, Wilson MG, Emslie G. An exploratory 
factor analysis of the Children’s Depression Rating Scale-Revised. J Child 
Adolesc Psychopharmacol (2006) 16(4):482–91. doi:10.1089/cap.2006.16.482 
52. March JS, Parker JD, Sullivan K, Stallings P, Conners CK. The 
Multidimensional Anxiety Scale for Children (MASC): factor structure, reli-
ability, and validity. J Am Acad Child Adolesc Psychiatry (1997) 36(4):554–65. 
doi:10.1097/00004583-199704000-00019 
53. Osman A, Gutierrez PM, Bagge CL, Fang Q, Emmerich A. Reynolds 
Adolescent Depression Scale-second edition: a reliable and useful instrument. 
J Clin Psychol (2010) 66(12):1324–45. doi:10.1002/jclp.20727 
54. Chung KF, Kan KK, Yeung WF. Assessing insomnia in adolescents: compar-
ison of Insomnia Severity Index, Athens Insomnia Scale and Sleep Quality 
Index. Sleep Med (2011) 12(5):463–70. doi:10.1016/j.sleep.2010.09.019
55. Greco LA, Baer RA, Smith GT. Assessing mindfulness in children and adoles-
cents: development and validation of the Child and Adolescent Mindfulness 
Measure (CAMM). Psychol Assess (2011) 23(3):606–14. doi:10.1037/a0022819 
56. Greco LA, Lambert W, Baer RA. Psychological inflexibility in childhood 
and adolescence: development and evaluation of the Avoidance and 
Fusion Questionnaire for youth. Psychol Assess (2008) 20(2):93–102. 
doi:10.1037/1040-3590.20.2.93 
57. Goodman R, Ford T, Richards H, Gatward R, Meltzer H. The Development 
and Well-Being Assessment: description and initial validation of an integrated 
assessment of child and adolescent psychopathology. J Child Psychol Psychiatry 
(2000) 41(5):645–55. doi:10.1111/j.1469-7610.2000.tb02345.x 
58. Brondbo H, Mathiassen B, Martinussen M, Heiervang E, Eriksen M, Kvernmo 
S. Agreement on web-based diagnoses and severity of mental health problems 
in Norwegian child and adolescent mental health services. Clin Pract Epidemol 
Ment Health (2012) 8:16–21. doi:10.2174/1745017901208010016 
59. Schumann G, Loth E, Banaschewski T, Barbot A, Barker G, Buchel C, et al. The 
IMAGEN study: reinforcement-related behaviour in normal brain function 
and psychopathology. Mol Psychiatry (2010) 15(12):1128–39. doi:10.1038/
mp.2010.4 
60. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. 
The Columbia-Suicide Severity Rating Scale: initial validity and internal 
consistency findings from three multisite studies with adolescents and adults. 
Am J Psychiatry (2011) 168(12):1266–77. doi:10.1176/appi.ajp.2011.10111704 
61. Hollingshead AB. Two Factor Index of Social Position. New Haven, CT: Mimeo 
(1957).
62. Bernstein DP, Ahluvalia T, Pogge D, Handelsman L. Validity of 
the Childhood Trauma Questionnaire in an adolescent psychiatric 
population. J Am Acad Child Adolesc Psychiatry (1997) 36(3):340–8. 
doi:10.1097/00004583-199703000-00012 
63. Walker EA, Unutzer J, Rutter C, Gelfand A, Saunders K, VonKorff M, et al. 
Costs of health care use by women HMO members with a history of childhood 
abuse and neglect. Arch Gen Psychiatry (1999) 56(7):609–13. doi:10.1001/
archpsyc.56.7.609 
64. Spinhoven P, Penninx BW, Hickendorff M, van Hemert AM, Bernstein DP, 
Elzinga BM. Childhood Trauma Questionnaire: factor structure, measure-
ment invariance, and validity across emotional disorders. Psychol Assess 
(2014) 26(3):717–29. doi:10.1037/pas0000002 
65. Campbell AH, Hemsley S. Outcome rating scale and session rating scale 
in psychological practice: clinical utility of ultra-brief measures. Clinical 
Psychologist (2011) 13(1):1–9. doi:10.1080/13284200802676391
66. Dannlowski U, Stuhrmann A, Beutelmann V, Zwanzger P, Lenzen T, Grotegerd 
D, et  al. Limbic scars: long-term consequences of childhood maltreatment 
revealed by functional and structural magnetic resonance imaging. Biol 
Psychiatry (2012) 71(4):286–93. doi:10.1016/j.biopsych.2011.10.021 
13
Henje Blom et al. TARA: RDoC-Based Adolescent Depression Treatment
Frontiers in Psychiatry | www.frontiersin.org January 2017 | Volume 7 | Article 208
67. Peng H, Ning Y, Zhang Y, Yang H, Zhang L, He Z, et al. White-matter density 
abnormalities in depressive patients with and without childhood neglect: a 
voxel-based morphometry (VBM) analysis. Neurosci Lett (2013) 550:23–8. 
doi:10.1016/j.neulet.2013.06.048 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2017 Henje Blom, Tymofiyeva, Chesney, Ho, Moran, Connolly, 
Duncan, Baldini, Weng, Acree, Goldman, Hecht and Yang. This is an open-access 
article distributed under the terms of the Creative Commons Attribution License 
(CC BY). The use, distribution or reproduction in other forums is permitted, 
provided the original author(s) or licensor are credited and that the original 
publication in this journal is cited, in accordance with accepted academic practice. 
No use, distribution or reproduction is permitted which does not comply with these 
terms.
